[HTML][HTML] Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials
B Spiess, S Rinaldetti, N Naumann, N Galuschek… - PLoS …, 2019 - journals.plos.org
… Standardization and quality control studies of 'real-time' quantitative reverse transcriptase
polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia…
polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia…
Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update
M Salmon, HE White, NCP Cross… - … Myeloid Leukemia, 2021 - Springer
… by reverse transcriptase polymerase chain reaction (RT-PCR) were initiated more than 30
… in complete cytogenetic remission (CCyR) on interferon alpha [7,8,9,10,11,12]. Competitive …
… in complete cytogenetic remission (CCyR) on interferon alpha [7,8,9,10,11,12]. Competitive …
[HTML][HTML] Chronic myeloid leukemia prognosis and therapy: criticisms and perspectives
D Russo, JV Garcia-Gutierrez, S Soverini… - Journal of Clinical …, 2020 - mdpi.com
… (allo-SCT) and interferon-alpha (IFNα) have been proven to … transcription polymerase chain
reaction (RT-qPCR) [6,7,8]. … Preservation of quiescent chronic myelogenous leukemia stem …
reaction (RT-qPCR) [6,7,8]. … Preservation of quiescent chronic myelogenous leukemia stem …
How we monitor the therapy effectiveness in patients with chronic myeloid leukemia-A Single center experience
S Mešanović, A Žugić-Jahić, S Hasić, V Simendić… - Genetics & …, 2023 - genapp.ba
… The quantitative real-time polymerase chain reaction method (… adherence in chronic
myelogenous leukemia in the chronic … after failure of interferon-alpha treatment. Blood 1;111(3):…
myelogenous leukemia in the chronic … after failure of interferon-alpha treatment. Blood 1;111(3):…
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
E Jabbour, H Kantarjian - American journal of hematology, 2020 - Wiley Online Library
… Baseline reverse transcriptase-polymerase chain reaction is … It acts via competitive inhibition
at the ATP-binding site of the … Given the equivalent efficacy and lower toxicity of lower dose …
at the ATP-binding site of the … Given the equivalent efficacy and lower toxicity of lower dose …
[HTML][HTML] Treatment-Free Remission—A New Aim in the Treatment of Chronic Myeloid Leukemia
P Kwaśnik, K Giannopoulos - Journal of Personalized Medicine, 2021 - mdpi.com
… The role of modern droplet digital polymerase chain reaction (… to the treatment of TKI, then
interferon alpha (IFN-α) therapy is … to the patient allows for careful monitoring of the patient. …
interferon alpha (IFN-α) therapy is … to the patient allows for careful monitoring of the patient. …
Human leukocyte antigen-B phenotype and minimal residual disease in chronic myeloid leukemia patients treated with imatinib: Is there an association?
E Hadad, A Ehsanpour, T Vosoughi… - Clinical Cancer …, 2020 - search.ebscohost.com
… ) in chronic myelogenous leukemia (CML) patients treated … by real‑time polymerase chain
reaction technique. Results: No … of the drugs used to treat cancer such as interferon‑alpha (…
reaction technique. Results: No … of the drugs used to treat cancer such as interferon‑alpha (…
[PDF][PDF] Chronic Myeloid Leukemia: Epidemiology, Diagnosis, Evaluation and Monitoring
S Abdul-Rahman, GA Hamid - researchgate.net
… The polymerase chain reaction (PCR) is one of the most … the survival of CML patients treated
with interferon-alpha –based … abnormality in chronic myelogenous leukaemia identified by …
with interferon-alpha –based … abnormality in chronic myelogenous leukaemia identified by …
Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA …
…, F Guilhot, French CML Group (FiLMC) - British Journal of …, 2023 - Wiley Online Library
… real-time quantitative polymerase chain reaction analysis on … for potential competing events
unrelated to CML or therapy. In … Finally, using an initial monitoring of the dose of dasatinib, …
unrelated to CML or therapy. In … Finally, using an initial monitoring of the dose of dasatinib, …
The Interferon-Alpha Revival in CML
M Talpaz, J Mercer, R Hehlmann - Chronic Myeloid Leukemia, 2021 - Springer
… wild-type cells in competitive repopulation assays [36]. … in monitoring or even predicting
response to IFNα therapy. … improve adherence to treatment without reducing efficacy, and …
response to IFNα therapy. … improve adherence to treatment without reducing efficacy, and …